Skip to content

Releases: Wang-Lin-boop/GeminiMol

[v1.3.0] GeminiMol Stable Version

01 Nov 10:35
Compare
Choose a tag to compare
Merge branch 'main' of https://github.com/Wang-Lin-boop/GeminiMol

[v1.2.1] GeminiMol

09 Mar 09:37
bee94f2
Compare
Choose a tag to compare

We have incorporated the PropPredictor.py script for predicting molecular properties by calling molecular property models. It supports the molecular property models trained using AutoQSAR.py or FineTuning.py.

[v1.1.1] GeminiMol

28 Dec 06:23
Compare
Choose a tag to compare

We have incorporated the PharmProfiler.py tool into our methodology, replacing the previous methods of virtual screening and target identification. The documentation for PharmProfiler has been added to provide detailed information on its usage and functionality.

[v1.0.0] GeminiMol

15 Dec 06:56
Compare
Choose a tag to compare

The molecular representation model is a neural network that converts molecular representations (SMILES, Graph) into feature vectors, that carries the potential to be applied across a wide scope of drug discovery scenarios. However, current molecular representation models have been limited to 2D or static 3D structures, overlooking the dynamic nature of small molecules in solution and their ability to adopt flexible conformational changes crucial for drug-target interactions. To address this limitation, we propose a novel strategy that incorporates the conformational space profile into molecular representation learning. By capturing the intricate interplay between molecular structure and conformational space, our strategy enhances the representational capacity of our model named GeminiMol. Consequently, when pre-trained on a miniaturized molecular dataset, the GeminiMol model demonstrates a balanced and superior performance not only on traditional molecular property prediction tasks but also on zero-shot learning tasks, including virtual screening and target identification. By capturing the dynamic behavior of small molecules, our strategy paves the way for rapid exploration of chemical space, facilitating the transformation of drug design paradigms.